BDSX
Income statement / Annual
Last year (2024), Biodesix, Inc.'s total revenue was $71.32 M,
an increase of 45.30% from the previous year.
In 2024, Biodesix, Inc.'s net income was -$42.93 M.
See Biodesix, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$71.32 M |
$49.09 M |
$38.21 M |
$54.51 M |
$45.56 M |
$24.55 M |
$20.43 M |
| Cost of Revenue |
$15.57 M
|
$13.01 M
|
$14.15 M
|
$30.52 M
|
$22.00 M
|
$6.07 M
|
$4.41 M
|
| Gross Profit |
$55.75 M
|
$36.08 M
|
$24.06 M
|
$23.99 M
|
$23.56 M
|
$18.48 M
|
$16.03 M
|
| Gross Profit Ratio |
0.78
|
0.73
|
0.63
|
0.44
|
0.52
|
0.75
|
0.78
|
| Research and Development Expenses |
$9.56 M
|
$9.99 M
|
$13.10 M
|
$12.79 M
|
$10.82 M
|
$10.47 M
|
$8.19 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$30.64 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$61.46 M
|
$50.52 M
|
$34.86 M
|
$0.00
|
$25.90 M
|
| Selling, General & Administrative Expenses |
$80.45 M
|
$67.39 M
|
$61.46 M
|
$50.52 M
|
$34.86 M
|
$30.64 M
|
$25.90 M
|
| Other Expenses |
$238.00 K
|
$44.00 K
|
$81.00 K
|
$1.62 M
|
$818.00 K
|
$4.11 M
|
$0.00
|
| Operating Expenses |
$90.25 M
|
$77.42 M
|
$74.65 M
|
$64.93 M
|
$46.49 M
|
$45.22 M
|
$34.09 M
|
| Cost And Expenses |
$105.82 M
|
$90.43 M
|
$88.80 M
|
$95.45 M
|
$68.49 M
|
$51.29 M
|
$38.49 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$55.00 K
|
$24.00 K
|
| Interest Expense |
$8.26 M
|
$9.54 M
|
$8.07 M
|
$4.51 M
|
$7.60 M
|
$3.01 M
|
$2.92 M
|
| Depreciation & Amortization |
$5.46 M
|
$5.51 M
|
$5.84 M
|
$3.18 M
|
$2.90 M
|
$2.79 M
|
$1.74 M
|
| EBITDA |
-$29.22 M |
-$37.10 M |
-$51.53 M |
-$35.47 M |
-$20.84 M |
-$24.93 M |
-$21.51 M |
| EBITDA Ratio |
-0.41
|
-0.76
|
-1.35
|
-0.65
|
-0.46
|
-1.02
|
-1.05
|
| Operating Income Ratio |
-0.48
|
-0.84
|
-1.32
|
-0.75
|
-0.5
|
-1.09
|
-1.15
|
| Total Other Income/Expenses Net |
-$8.43 M
|
-$10.80 M
|
-$14.86 M
|
-$2.22 M
|
-$8.42 M
|
-$3.99 M
|
-$2.71 M
|
| Income Before Tax |
-$42.93 M
|
-$52.15 M
|
-$65.45 M
|
-$43.16 M
|
-$31.35 M
|
-$30.73 M
|
-$26.17 M
|
| Income Before Tax Ratio |
-0.6
|
-1.06
|
-1.71
|
-0.79
|
-0.69
|
-1.25
|
-1.28
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$211.00 K
|
| Net Income |
-$42.93 M
|
-$52.15 M
|
-$65.45 M
|
-$43.16 M
|
-$31.35 M
|
-$30.73 M
|
-$26.17 M
|
| Net Income Ratio |
-0.6
|
-1.06
|
-1.71
|
-0.79
|
-0.69
|
-1.25
|
-1.28
|
| EPS |
-6.6 |
-12.8 |
-31 |
-31.6 |
-6.48 |
-0.67 |
-19.8 |
| EPS Diluted |
-6.6 |
-12.8 |
-31 |
-31.6 |
-6.48 |
-0.67 |
-19.8 |
| Weighted Average Shares Out |
$6.48 M
|
$4.11 M
|
$2.11 M
|
$1.37 M
|
$4.84 M
|
$45.71 M
|
$1.33 M
|
| Weighted Average Shares Out Diluted |
$6.48 M
|
$4.11 M
|
$2.11 M
|
$1.37 M
|
$4.84 M
|
$45.71 M
|
$1.33 M
|
| Link |
|
|
|
|
|
|
|
